Updates on Clostridioides difficile in Europe Advances in Microbiology, Infectious Diseases and Public Health Volume 18 /
This fully updated second edition outlines the currently available clinical, epidemiological and experimental data on Clostridioides difficile infections(CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last...
保存先:
| 団体著者: | |
|---|---|
| その他の著者: | , |
| フォーマット: | 電子媒体 eBook |
| 言語: | 英語 |
| 出版事項: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| 版: | 2nd ed. 2024. |
| シリーズ: | Advances in Microbiology, Infectious Diseases and Public Health,
1435 |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1007/978-3-031-42108-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-42108-2 | ||
| 003 | DE-He213 | ||
| 005 | 20250807135644.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240104s2024 sz | s |||| 0|eng d | ||
| 020 | |a 9783031421082 |9 978-3-031-42108-2 | ||
| 024 | 7 | |a 10.1007/978-3-031-42108-2 |2 doi | |
| 050 | 4 | |a QR46 | |
| 072 | 7 | |a MMFM |2 bicssc | |
| 072 | 7 | |a MED052000 |2 bisacsh | |
| 072 | 7 | |a MKFM |2 thema | |
| 082 | 0 | 4 | |a 616.9041 |2 23 |
| 245 | 1 | 0 | |a Updates on Clostridioides difficile in Europe |h [electronic resource] : |b Advances in Microbiology, Infectious Diseases and Public Health Volume 18 / |c edited by Paola Mastrantonio, Maja Rupnik. |
| 250 | |a 2nd ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2024. | |
| 300 | |a X, 362 p. 28 illus., 25 illus. in color. |b online resource. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of color is not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background color |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 490 | 1 | |a Advances in Microbiology, Infectious Diseases and Public Health, |x 2365-2683 ; |v 1435 | |
| 505 | 0 | |a Economic burden of Clostridioides difficile infection in European countries -- The need for European surveillance of CDI.-Diagnostic guidance for C. difficile infections -- European practice for CDI treatment -- Faecal microbiota transplantation as emerging treatment in European countries 2.0 -- Probiotics for prevention and treatment of Clostridioides difficile infection -- Immunization strategies against Clostridioides difficile -- Ribotypes and new virulent strains across Europe -- Antibiotic resistances of Clostridioides difficile -- Comparative genomics of Clostridioides difficile -- An updated view on the cellular uptake and mode-of-action of Clostridioides difficile toxins -- Clostridioides difficile biofilm -- Clostridioides difficile sporulation -- Membrane vesicles of C.difficile and other Clostridial species -- Non-human C.difficile reservoirs and sources: animals,food, environment -- The ESCMID Study Group for Clostridioides difficile : history, role and perspectives. | |
| 520 | |a This fully updated second edition outlines the currently available clinical, epidemiological and experimental data on Clostridioides difficile infections(CDI) with special emphasis on studies and results achieved in Europe. The incidence and severity of CDI has increased significantly over the last decade, and the book explains why C. difficile, recently reclassified as Clostridioides difficile, remains a significant challenge, also from economic perspective, to health care systems all over the world. The different reservoirs of this ubiquitous microorganism are reviewed as well as the different factors contributing to its virulence, such as toxins and biofilm formation. The rapid evolution of antibiotic resistance is clearly a concern and in a specific way can influence the CDI epidemiology. Additionally, new emerging strains and comparative genomics studies are taken into consideration for their relevance from epidemiological and evolutionary point of view. The book also gives an overview on diagnostics, therapy and surveillance, all of which are still challenging. Therefore, a closer look is taken on the effect of probiotics as an alternative to antibiotics, for prevention and treatment of CDI. Fecal transplantation from healthy donors, passive immunotherapies and vaccines for patients with recurrences are also discussed in dedicated chapters. New topics included sporulation and membrane vesicles in C. difficile. The book closes with a summary of the history and the achievements of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Clostridium difficile (ESGCD) written by the current and past presidents of the Society. It is the aim of this book to raise awareness on CDI and to disseminate updated information on its prevention, diagnosis and treatment. | ||
| 532 | 8 | |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 650 | 0 | |a Medical microbiology. | |
| 650 | 0 | |a Diseases. | |
| 650 | 0 | |a Microbiology. | |
| 650 | 1 | 4 | |a Medical Microbiology. |
| 650 | 2 | 4 | |a Diseases. |
| 650 | 2 | 4 | |a Microbiology. |
| 700 | 1 | |a Mastrantonio, Paola. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Rupnik, Maja. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031421075 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031421099 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031421105 |
| 830 | 0 | |a Advances in Microbiology, Infectious Diseases and Public Health, |x 2365-2683 ; |v 1435 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-42108-2 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||